References
- Allaart JG, van Asten AJAM, Vernooij JCM, Gröne A. Beta2 toxin is not involved in in vitro cell cytotoxicity caused by human and porcine cpb2-harbouring Clostridium perfringens. Vet Microbiol. 2014;171(1–2):132–138. https:/doi.org/10.1016/j.vetmic.2014.03.020
- Brzychczy-Włoch M, Bulanda M. Analysis of genetic similarities between Clostridium perfringens isolates isolated from patients with gas gangrene and from hospital environment conducted with the use of the PFGE method. Pol J Surg. 2014;86(3):141–146. https:/doi.org/10.2478/pjs-2014-0026
- Brzychczy-Włoch M, Ochońska D, Piotrowska A, Bulanda M. Gas gangrene of different origin associated with Clostridium perfringens type A in three patients simultaneously hospitalized in a single department of Orthopedics and Traumatology in Poland. Pol J Microbiol. 2016;65(4):399–406. https:/doi.org/10.5604/17331331.1227665
- Johansson A, Aspan A, Bagge E, Båverud V, Engström BE, Johansson KE. Genetic diversity of Clostridium perfringens type A isolates from animals, food poisoning outbreaks and sludge. BMC Microbiol. 2006;6(1):47. https:/doi.org/10.1186/1471-2180-6-47
- Kędzielska J, Obuch-Woszczatyński P, Pituch H, Młynarczyk G. [Clostridium perfringens as the etiological agent of antibiotic associated diarrhea] (in Polish). Postepy Mikrobiol. 2012;51(1):17–25.
- Kiu R, Caim S, Alexander S, Pachori P, Hall LJ. Probing genomic aspects of the multi-host pathogen Clostridium perfringens reveals significant pangenome diversity, and a diverse array of virulence factors. Front Microbiol. 2017;8:2485. https:/doi.org/10.3389/fmicb.2017.02485
- Kuzaka B, Wróblewska MM, Borkowski T, Kawecki D, Kuzaka P, Młynarczyk G, Radziszewski P. Fournier’s gangrene: clinical presentation of 13 cases. Med Sci Monit. 2018;24:548–555. https:/doi.org/10.12659/MSM.905836
- Maslanka SE, Kerr JG, Williams G, Barbaree JM, Carson LA, Miller JM, Swaminathan B. Molecular subtyping of Clostridium perfringens by pulsed-field gel electrophoresis to facilitate food-borne-disease outbreak investigations. J Clin Microbiol. 1999;37(7): 2209–2214.
- Myers GSA, Rasko DA, Cheung JK, Ravel J, Seshadri R, DeBoy RT, Ren Q, Varga J, Awad MM, Brinkac LM, et al. Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res. 2006;16(8):1031–1040. https:/doi.org/10.1101/gr.5238106
- Navarro M, McClane B, Uzal F. Mechanisms of action and cell death associated with Clostridium perfringens toxins. Toxins (Basel). 2018;10(5):212. https:/doi.org/10.3390/toxins10050212
- Park M, Deck J, Foley SL, Nayak R, Songer JG, Seibel JR, Khan SA, Rooney AP, Hecht DW, Rafii F. Diversity of Clostridium perfringens isolates from various sources and prevalence of conjugative plasmids. Anaerobe. 2016;38:25–35. https:/doi.org/10.1016/j.anaerobe.2015.11.003
- Rood JI, Adams V, Lacey J, Lyras D, McClane BA, Melville SB, Moore RJ, Popoff MR, Sarker MR, Songer JG, et al. Expansion of the Clostridium perfringens toxin-based typing scheme. Anaerobe. 2018;53:5–10. https:/doi.org/10.1016/j.anaerobe.2018.04.011
- Stevens DL, Aldape MJ, Bryant AE. Life-threatening clostridial infections. Anaerobe. 2012;18(2):254–259. https:/doi.org/10.1016/j.anaerobe.2011.11.001
- Stevens DL, Bryant AE. Necrotizing Soft-Tissue Infections. N Engl J Med. 2017;377(23):2253–2265. https:/doi.org/10.1056/NEJMra1600673
- EUCAST. Breakpoint tables for interpretation of MICs and zone diameters Ver. 7.1 [Internet]. Basel (Switzerland): European Committee on Antimicrobial Susceptibility Testing; 2017 [cited 2019 Jan 21]. Available from http://www.eucast.org/ast_of_bacteria/previous_versions_of_documents/
- van Belkum A, Tassios PT, Dijkshoorn L, Haeggman S, Cookson B, Fry NK, Fussing V, Green J, Feil E, Gerner-Smidt P, et al.; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group on Epidemiological Markers (ESGEM). Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect. 2007;13 Suppl 3:1–46. https:/doi.org/10.1111/j.1469-0691.2007.01786.x
- van Asten AJAM, Nikolaou GN, Gröne A. The occurrence of cpb2-toxigenic Clostridium perfringens and the possible role of the β2-toxin in enteric disease of domestic animals, wild animals and humans. Vet J. 2010;183(2):135–140. https:/doi.org/10.1016/j.tvjl.2008.11.005
- Wróblewska M, Kuzaka B, Borkowski T, Kuzaka P, Kawecki D, Radziszewski P. Fournier’s gangrene – current concepts. Pol J Microbiol. 2014;63(3):267–273.
- Xiao Y, Wagendorp A, Moezelaar R, Abee T, Wells-Bennik MHJ. A wide variety of Clostridium perfringens type A food-borne isolates that carry a chromosomal cpe gene belong to one multilocus sequence typing cluster. Appl Environ Microbiol. 2012;78(19): 7060–7068. https:/doi.org/10.1128/AEM.01486-12
- Żaba R, Grzybowski A, Prokop J, Żaba Z, Żaba C. Fournier’s gangrene: historical survey, current status, and case description. Med Sci Monit. 2009;15(2):CS34–CS39.